Results
A total of 52 SCH patients were included in the study. Mean age of the
patients was 50.86 ±13.11 years (18–75). 25 were male and 27 were
females. 35 patients have once SCH and 17 patients have more than two
(Table 1). The mean and standard deviation of laboratory results of all
patients, and patients who have SCH once and two or more were given at
the table 2. One patient with once and one patient with recurrent SCH
(3.8%) were diagnosed a type I vWD (table 3). The prevalence of type 1
vWD in the study was not statistically significant when compared with
the frequency of vWD in the Turkish population.
Fibrinogen level was found to be statistically higher in patients who
had SCH once than those who had recurrent SCH (p=0.048). But
fibrinogen level was in normal range in all patients. Thrombin time was
studied in a small number of patients and all results were in normal
range. Dysfibrinogenemia was not considered clinically in any patient.
There were 12 patients who reported a previous history of bleeding. The most frequently reported symptoms, in order of frequency, are recurrent skin and mucosal bleeding, minor post-traumatic bleeding, menorrhagia and recurrent epistaxis.